IP Verse

Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells

Patent No. EP3059307 (titled "Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells") was filed by Inserm Institut National DE LA Sant ET DE LA Recherche Mdicale on Feb 20, 2015. The application was issued on May 4, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CYTOCHROMAJul 17, 2019OUZMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3059307

INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE
Application Number
EP15305265A
Filing Date
Feb 20, 2015
Status
Patent Maintained As Amended
Apr 2, 2022
Publication Date
May 4, 2022
External Links
Slate, Register , Google Patents